Literature DB >> 9146600

Comparative results of goal oriented therapy for erectile dysfunction.

K A Hanash1.   

Abstract

PURPOSE: Goal oriented therapy for erectile dysfunction, based on a complete education of the couple, was offered to 460 patients. The short-term and long-term results of the first and second treatments selected were compared.
MATERIALS AND METHODS: From September 1991 to March 1995, 460 patients with erectile dysfunction were evaluated and treated prospectively. The success of treatment, selected by the patient or couple, was defined as the ability to achieve and maintain good erections for successful coitus for at least 1 year after the start of therapy. Sexual satisfaction of the couple was required to confirm a successful outcome.
RESULTS: The preferred first line of treatment by 322 patients was pharmacotherapy, with intracavernous injections being the second most selected therapy (80% success rate). However, there was a high long-term dropout rate for intracavernous injections. Approximately 70% of the patients were lost to followup or refused further treatment.
CONCLUSIONS: Overall, this prospective study showed that goal oriented therapy is initially highly successful. However, the long-term high dropout rate and dissatisfaction of the couple cast doubt about the efficacy of the present treatment options.

Entities:  

Mesh:

Year:  1997        PMID: 9146600

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

Review 1.  Economic cost of male erectile dysfunction using a decision analytic model: for a hypothetical managed-care plan of 100,000 members.

Authors:  H L Tan
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

2.  The cost to the United Kingdom National Health Service of managing erectile dysfunction: the impact of sildenafil and prescribing restrictions.

Authors:  Edward C F Wilson; Emma S McKeen; Paul A Scuffham; Martin C J Brown; Kevan Wylie; Geoff Hackett
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

3.  The effect of sildenafil citrate and pentoxifylline combined treatment in the management of erectile dysfunction.

Authors:  Ozdem Levent Ozdal; Cuneyt Ozden; Serkan Gokkaya; Guvenc Urgancioglu; Binhan Kagan Aktas; Ali Memis
Journal:  Int Urol Nephrol       Date:  2007-09-01       Impact factor: 2.370

Review 4.  Future prospects in the treatment of erectile dysfunction: focus on avanafil.

Authors:  Amjad Alwaal; Raed Al-Mannie; Serge Carrier
Journal:  Drug Des Devel Ther       Date:  2011-10-18       Impact factor: 4.162

5.  The application of color Doppler flow imaging in the diagnosis and therapeutic effect evaluation of erectile dysfunction.

Authors:  Xu-Jun Xuan; Gang Bai; Cai-Xia Zhang; Chao Xu; Fu-Ding Lu; Yang Peng; Gang Ma; Cong-Hui Han; Jun Chen
Journal:  Asian J Androl       Date:  2016 Jan-Feb       Impact factor: 3.285

Review 6.  Understanding the cellular basis and pathophysiology of Peyronie's disease to optimize treatment for erectile dysfunction.

Authors:  Jeffrey Campbell; Raidh Alzubaidi
Journal:  Transl Androl Urol       Date:  2017-02

7.  Preference for and adherence to oral phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction.

Authors:  Konstantinos Giannitsas; Angelis Konstantinopoulos; Christos Patsialas; Petros Perimenis
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

8.  Influence of substance use on the erectile response in a sample of drug users.

Authors:  Francisco Javier Del Río; Francisco Cabello; Inmaculada Fernández
Journal:  Int J Clin Health Psychol       Date:  2014-11-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.